Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Sera Prognostics stock (Sera Prognostics)

Buy Sera Prognostics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Sera Prognostics is a medical devices business based in the US. Sera Prognostics shares (SERA) are listed on the NASDAQ and all prices are listed in US Dollars. Sera Prognostics employs 55 staff and has a trailing 12-month revenue of around $206,000.

Our top picks for where to buy Sera Prognostics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $1,000 in stock
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Sera Prognostics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – SERA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Sera Prognostics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Sera Prognostics stock price (NASDAQ: SERA)

Use our graph to track the performance of SERA stocks over time.

Sera Prognostics shares at a glance

Information last updated 2024-07-06.
Latest market close$5.31
52-week range$1.52 - $12.36
50-day moving average $8.39
200-day moving average $6.34
Wall St. target price$2.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.07

Is it a good time to buy Sera Prognostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sera Prognostics price performance over time

Historical closes compared with the close of $5.31 from 2024-07-10

1 week (2024-07-05) -1.48%
1 month (2024-06-12) -35.40%
3 months (2024-04-12) -45.03%
6 months (2024-01-12) -19.30%
1 year (2023-07-12) 62.39%
2 years (2022-07-12) 191.76%
3 years (2021-07-08) N/A
5 years (2019-07-08) N/A

Sera Prognostics financials

Revenue TTM $206,000
Gross profit TTM $75,000
Return on assets TTM -24.03%
Return on equity TTM -43.59%
Profit margin 0%
Book value $1.99
Market Capitalization $176 million

TTM: trailing 12 months

Sera Prognostics share dividends

We're not expecting Sera Prognostics to pay a dividend over the next 12 months.

You may also wish to consider:

Sera Prognostics share price volatility

Over the last 12 months, Sera Prognostics's shares have ranged in value from as little as $1.52 up to $12.355. A popular way to gauge a stock's volatility is its "beta".

SERA.US volatility(beta: 1.05)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sera Prognostics's is 1.051. This would suggest that Sera Prognostics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Sera Prognostics's beta into context you can compare it against those of similar companies.

Sera Prognostics overview

Sera Prognostics, Inc. , a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. .

Frequently asked questions

What percentage of Sera Prognostics is owned by insiders or institutions?
Currently 13.105% of Sera Prognostics shares are held by insiders and 66.075% by institutions.
How many people work for Sera Prognostics?
Latest data suggests 55 work at Sera Prognostics.
When does the fiscal year end for Sera Prognostics?
Sera Prognostics's fiscal year ends in December.
Where is Sera Prognostics based?
Sera Prognostics's address is: 2749 East Parleys Way, Salt Lake City, UT, United States, 84109
What is Sera Prognostics's ISIN number?
Sera Prognostics's international securities identification number is: US81749D1072

More guides on Finder

Ask a Question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site